Obesity Surgery: Opioid Sparing Care Pathway

We are studying a new pain management approach for patients undergoing obesity surgery to see if it helps reduce opioid use and improve recovery. This may lead to better health outcomes and less reliance on pain medications.

>2 yearsMonitoring phase (IV)No PlaceboStandard MedicinesInjectionInternal MedicineOtolaryngology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Dexmedetomidine
Dexmedetomidine is a sedative substance used to calm patients and reduce anxiety and pain during surgery or in intensive care.
Esketamine
Esketamine is a fast-acting antidepressant substance used to relieve depression symptoms when other treatments haven't worked.
Lidocaine Hydrochloride Monohydrate
Lidocaine hydrochloride monohydrate is a local anesthetic substance used to numb skin and tissues for minor procedures and pain relief.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Region Oerebro Laen
Lindesberg Lasarett, Department of Anesthesia and Intensive Care, Stentäppsgatan 6, 71182 Lindesberg
Örebro, Sweden
Sahlgrenska University Hospital-Vastra Gotalandsregionen
Department of Anesthesia and Intensive Care, Diagnosvägen 11, 416 50 Gothenburg
Partille, Sweden
Sponsor: Vaestra Goetalandsregionen
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.